ArticleCell death & disease2023

CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.

Yu-Ching Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.